Investigating the immunotoxic effects of exposure to chemicals usually comprises evaluation of weight and histopathology of lymphoid tissues, various lymphocyte parameters in the circulation, and immune function. Immunotoxicity assessment is time consuming in humans or requires a high number of animals, making it expensive. Furthermore, reducing the use of animals in research is an important ethical and political issue. Immunotoxicogenomics represents a novel approach to investigate immunotoxicity able of overcoming these limitations. The current research, embedded in the European Union project NewGeneris, aimed to retrieve gene expression profiles that are indicative of exposure to immunotoxicants. To this end, whole-genome gene expression was investigated in human peripheral blood mononuclear cells in response to in vitro exposure to a range of immunotoxic chemicals (4-hydroxy-2-nonenal, aflatoxin B1, benzo [a]pyrene, deoxynivalenol, ethanol, malondialdehyde, polychlorinated biphenyl 153, and 2,3,7,8-tetrachlorodibenzo-pdioxin) and nonimmunotoxic chemicals (acrylamide, dimethylnitrosamine, 2-amino-3-methyl-3H-imidazo[4,5-F] quinoline, and 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine). Using Agilent oligonucleotide microarrays, whole-genome gene expression profiles were generated, which were analyzed using Genedata's Expressionist software. Using Recursive Feature Elimination and Support Vector Machine, a set of 48 genes was identified that distinguishes the immunotoxic from the nonimmunotoxic compounds. Analysis for enrichment of biological processes showed the gene set to be highly biologically and immunologically relevant. We conclude that we have identified a promising transcriptomic profile indicative of immunotoxic exposure.
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Over the last decades, there has been an increased incidence of immune-related disorders (Asher et al., 2006; International Programme on Chemical Safety, 1996 ; The DIAMOND Project Group, 2006) . In part, the development of these diseases might be associated with exposure to hazardous dietary and environmental chemicals (Carpenter, 2006; Dietert, 2009) . Investigating the effects of immunotoxic exposure usually comprises evaluation of weight and histopathology of lymphoid organs, lymphoid markers in the circulation, and immune function. This often is time consuming in humans or requires a high number of animals, making it expensive. Furthermore, reducing the use of animals in research is an important ethical and political issue. A novel genomics-based approach of investigating immunotoxicity able to overcome these limitations has been previously described as immunotoxicogenomics (Baken et al., 2007; Luebke et al., 2006) . Besides assessing immunotoxic effects, immunotoxicogenomics can provide mechanistic insights and could be used to develop immunotoxicity biomonitoring parameters. It already has been shown that gene expression profiling is a promising tool for the development of new biomarkers in toxicology and molecular epidemiology (Baken et al., 2007; van Leeuwen et al., 2008) . Several microarray gene expression studies have been published regarding immunotoxicity using chemical compounds such as benzo [a] pyrene (BaP), cyclosporin A, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), bis(tri-n-butyltin)oxide (TBTO), and mycotoxins such as deoxynivalenol (DON) (Baken et al., 2006 (Baken et al., , 2008 Kinser et al., 2004; Zeytun et al., 2002) . However, these studies have focused on animals.
The objective of our research, which is embedded in the European Union project NewGeneris (Merlo et al., 2009) , is to retrieve a transcriptomic profile indicative of exposure to immunotoxic compounds by investigating whole-genome gene expression in human peripheral blood mononuclear cells (PBMC) in response to in vitro exposure to a range of
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immunotoxic and nonimmunotoxic chemicals. The compounds tested belong to various chemical classes and are present in food and/or the environment, therefore representing frequently encountered exposures. Among the chemicals tested are wellknown immunotoxicants such as BaP, TCDD, and polychlorinated biphenyls (PCB) (de Jong et al., 1999; Heilmann et al., 2006; Kerkvliet, 2002) .
MATERIALS AND METHODS
Blood collection and PBMC isolation. Upon signing informed consent,~50 ml of blood was drawn from healthy, nonsmoking 25-to 30-year-old Norwegian volunteers (25 males and 35 females), into sodium heparinized vacutainers (Becton Dickinson, Plymouth, UK), using a butterfly blood collection set (Becton Dickinson, Franklin Lakes, NJ). The experiments were approved by the Regional Committee for Ethics in Medical Research in Oslo, Norway. Volunteers reported to be free of medication at the time of sampling. Isolation of PBMC from whole blood was performed using FicollPaque (GE Healthcare Bio-Sciences AB, Uppsala, Sweden) in Leucosep filter tubes (Greiner Bio-One, Frickenhausen, Germany) according to the manufacturers' protocol. The cells were resuspended in tissue culture medium RPMI 1640 supplemented with L-glutamine, 10% heat-inactivated fetal calf serum (Gibco, Paisley, UK), and 100 U/ml penicillin G and 0.1 mg/ml streptomycin (PAA Laboratories GmbH, Pasching, Austria) to a final concentration of 2.4 3 10 6 cells/ml.
Chemicals. Test chemicals are presented in Table 1 and were purchased from Sigma-Aldrich (St Louis, MO), except for the following: 2-amino-3-methyl-3H-imidazo[4,5-F]quinoline (IQ) and 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) were purchased from Toronto Research Chemicals (North York, Canada), TCDD from Accustandard (New Haven, CT), 4-hydroxy-2-nonenal (4-HNE) from Calbiochem (San Diego, CA), and 100% ethanol from Arcus (Oslo, Norway). Stock solutions of the different chemicals were made by dissolving the substances in dimethyl sulfoxide (DMSO; Sigma-Aldrich) except for ethanol and DON that were solved in sterile PBS (10mM, pH 7.4; Norwegian Institute of Public Health, Oslo, Norway). The stock solutions were diluted (10-fold dilutions) in solvents before further dilution in culture medium. The final culture concentrations of DMSO and PBS were less than 0.5%.
Metabolic activation system. A human liver S9-mix was used for in vitro metabolic activation of the compounds. Human liver S9 fraction from a pool of 15 male and female Caucasian donors was purchased from Celsis (In Vitro Technologies, Baltimore, MA). Immediately before use, 10% S9-mix containing 30% S9 fraction was added to the medium as previously described (van Leeuwen et al., 2005) .
Concentration range findings. PBMC from at least two healthy volunteers per chemical were exposed overnight to at least five serial dilutions of each chemical. Concentrations that caused more than 10% cytotoxicity, based on the Trypan Blue Exclusion test, were excluded for further analysis.
Time range findings. For time range finding, cells were exposed to the 100% concentration of a selection of the 12 chemicals, i.e., BaP, DON, PhIP, and TCDD for 3, 6, 18, or 24 h. Real-time quantitative PCR was performed on eight genes, representing different relevant biological cellular processes, to determine the optimal exposure time, i.e., the time at which the highest overall response of the gene expression was observed. To determine the effects of S9 on BaP metabolism/activation, a sample without S9-mix was included at the 24-h incubation. Real-time quantitative PCR was performed as described by van Leeuwen et al. (2008) PBMC exposure. For analysis of whole-genome gene expression by microarray, mitogen-induced cell proliferation, and cytokine release, PBMC from five independent donors per compound were exposed for 20 h to three concentrations, i.e., the 100%, two serial 10-fold dilutions (10 and 1%), and a DMSO or PBS vehicle control. All exposures were performed in the presence of freshly prepared S9-mix.
Mitogen-induced cell proliferation and cytokine release. Mitogen-induced cell proliferation and cytokine release were measured as described by Stølevik et al. (unpublished data) . In short, after exposure, the culture medium was removed and fresh medium with the mitogen phytohemagglutinin (10 lg/ ml) was added. After further incubation for 48 h, levels of nine selected cytokines (interleukin [IL]-1b, IL-2, IL-4, IL-10, IL-13, IL-17, granulocyte colony stimilating factor, interferon gamma, and tumor necrosis factor-alpha) in the supernatant as well as cell proliferation were measured by Luminex Technology and BrdU incorporation assay, respectively.
Designation toxicity of test conditions. In order to assess the toxicity of the 100, 10, and 1% concentration of each compound, we designated the different conditions as either immunotoxic, nonimmunotoxic, or cytotoxic based on data on viability, suppression of immune proliferation, and cytokine release as well as the existing knowledge about immunotoxicity of the 12 different compounds. First, compounds were considered to be immunotoxic or nonimmunotoxic based on literature (Table 1) . Second, nonimmunotoxic compounds were considered to be cytotoxic in case of rigorous suppression of proliferation (! 50% compared with control), even if viability before mitogen stimulation was unaffected (not lower than 90%). For immunotoxic compounds, in case of rigorous suppression of proliferation, cytokine release was taken as an indicator. In cases where all cytokines tested were significantly reduced by the chemical exposure in conjunction with suppression of proliferation, we assumed that this did not represent immunotoxicity but rather the loss of functionality due to cytotoxicity. In cases, however, of reduction of the proliferative capacity but presence of cytokine production (or even upregulation), the cells were considered to still be functional. This condition was then considered to represent immunotoxicity. Based on these considerations, every outcome at the different concentrations for the different chemicals was evaluated, and all conditions were then identified as immunotoxic, nonimmunotoxic, or cytotoxic, as presented in Table 1 .
RNA isolation. Upon removal of culture medium after exposures, cells were disrupted and homogenized in TRIzol (Invitrogen, Paiseley, UK) and stored at À80°C. RNA was isolated according to the manufacturer's instructions. Subsequent RNA purification was performed using the RNeasy Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. RNA yield was assessed spectrophotometrically, and RNA quality was determined by automated gel electrophoresis (Bioanalyzer 2100; Agilent Technologies, Amstelveen, The Netherlands). Samples with RNA Integrity Numbers ! 6 were considered to be of sufficient quality.
Gene expression analysis. Microarray analysis was performed using whole-genome Agilent 4 3 44K microarrays (Agilent Technologies, Palo Alto, CA). One microgram of total RNA was used for the generation of fluorophorelabeled cRNA using the Low Input RNA Linear Amplification method (Agilent Technologies). First, total RNA was reversely transcribed into complementary DNA (cDNA) using T7-promoter primer and MMLV reverse transcriptase. Subsequently, the cDNA was transcribed into fluorescently labeled cyanineCTPm cRNA (Agilent Technologies). Exposed samples were always labeled with Cy5, whereas the vehicle control samples were labeled with Cy3. Samples were purified using the RNeasy Mini Kit (Qiagen, Venlo, The Netherlands), and fluorophore incorporation efficiency and amplification were determined spectrophotometrically. Microarray slides were subsequently hybridized with the paired Cy5-Cy3 mixture for 17 h at 60°C. Slides were washed with wash buffers, including Agilent Stabilization and Drying Solution, which contains an ozone-scavenging compound dissolved in acetonitrile in order to protect against ozone-induced degradation of cyanine dyes, in particular Cy5 (Agilent Technologies). After washing, slides were scanned on a GenePix 4000B Microarray Scanner (Molecular Devices, Sunnyvale). Laser power was set to 100%. The photo multiplier tube gain was set to a saturation tolerance of 0.02% to minimize background and saturated spots.
Microarray data analysis. The images obtained (resolution 5 l, 16 bit tiff image) were processed with Imagene 8.0.1 software (Biodiscovery, El Segundo) to extract signal intensities for spots and local backgrounds. Poor spots were flagged automatically. The data were preprocessed using the Refiner Array module from the Genedata Expressionist Ó system (Genedata AG, Basel, Switzerland). Raw data were assessed for quality and preprocessed as follows. The Bayesian Background Corrector was used to correct values by subtracting backgrounds without producing negative values. Next, the contrast was diagnosed, i.e., the quality for each signal according to its signal-to-noise ratio Conditions were designated as immunotoxic (ITX), nonimmunotoxic (NITX), or cytotoxic (CTX) based on the existing knowledge about immunotoxicity as well as data on suppression of immune proliferation and cytokine release, as described by Stølevik, Nygaard, Namork, Granum, Pellerud, van Leeuwen, Gmuender, van Delft, van Loveren, and Løvik (unpublished data). a For the last four compounds, no (strong) evidence in literature was found that they are immunotoxic and were therefore designated to be nonimmunotoxic TRANSCRIPTOMIC IMMUNOTOXICITY PROFILE was assessed. For each array, distortion and imbalance was determined and corrected for. Defective areas on the arrays were diagnosed, and defective features were masked. A signal-dependent normalization that removes any nonlinearity between the two channels was performed, i.e., LOWESS correction. Lastly, all array values were condensed. The Analyst module from the Genedata Expressionist
Ó system was used to analyze the data set. For each compound, differentially expressed genes were selected by applying three different filtering criteria: (I) fold change ! 1.5 or 0.67 (average signals calculated on log values) and a coefficient of variance 0.5, (II) fold change ! 1.5 or 0.67 in three of five donors (three of four for dimethylnitrosamine [DMNA] 10% due to missing experiment because of bad array quality), or (III) a p value < 0.001 in a t-test of experiment versus control, analyzing the values from the two channels as separate experiments after a median normalization. The reasoning for setting the p value threshold to < 0.001 was that the expected number of transcripts with p values below the threshold is about 18 assuming random effects only (~18,000 transcripts with at least 50% valid values per group on the microarray). To highlight similarities and differences between the different compounds and classes, principal component analysis (PCA) was applied. Log2-transformed intensities of both filtered and unfiltered data sets were uploaded into the PCA module of ArrayTrack (Tong et al., 2003) .
Recursive Feature Elimination (RFE) based on Support Vector Machine (SVM), also referred to as SVM-RFE, was used to determine the key transcripts in distinguishing the immunotoxic from the nonimmunotoxic conditions. After its introduction by Guyon et al. (2002) , this method has been successfully applied in several gene expression studies as well as in other fields of research for selecting important features (Duan and Rajapakse, 2005) . For each of the three filtering criteria mentioned above, the union of all differentially expressed transcripts over all included conditions was used as input for the three ranking tests, generating three different gene lists. Subsequently, the intersection of the top 100 of these three lists was selected. Alternatively, SVM-RFE was performed taking the union or the intersection of the three filtered data sets. The Venn diagram was created using the online tool VENNY (Oliveros, J.C., 2007; an interactive tool for comparing lists with Venn Diagrams: http:// bioinfogp.cnb.csic.es/tools/venny/index.html).
For functional interpretation of the gene set, the GO-Elite v1.19beta tool was used (http://www.genmapp.org/go_elite/go_elite.html). GO-Elite mainly filters significant gene ontology (GO) processes out of a redundant GO list. This filtering was done based on three criteria: (I) every GO process must contain at least two genes, (II) the permuted p value of a GO process (n ¼ 2000 permutation cycles) must be < 0.05, and (III) the calculated z-score has to be higher than 1.96. The GO OBO database used was downloaded on 26 May 2009 . The Agilent reporter IDs were converted to EnsEMBL IDs using a custom annotation approach (Gaj et al., 2007) .
Validation by real-time quantitative PCR. In order to validate our findings, real-time quantitative PCR was performed. Correlation analysis with microarray data of the overall (annotated) top five transcripts was used to evaluate the reported transcriptional changes, i.e., FN1, FEZ1, SPP1, GPNMB, and THBS1. Experiments were performed as described by van Leeuwen et al. (2008) . Primer sequences (5#-3#) used were as follows: THBS1: forward CATGCCACGGCCAACAA, reverse TGGCCCAGGTAGTTGCACTT; FN1: forward GAATATCTCGGTGCCATTTGC, reverse CCAGGTCTGCGG-CAGTTG; SPP1: forward CAGCCACAAGCAGTCCAGATTATA, reverse CCTGACTATCAATCACATCGGAAT; FEZ 1: forward ACAAACATTCT-CTTTGCCATGAAG, reverse GTTAGGTAGGGCAGAGCACTTTTAA; GPNMB: forward TCTAAGATCATGTTCCAAGCTAACTGA, reverse GGCTTGGGCCTGTTATTGTTC; and ACTB: forward CCTGGCACCCAG-CACAAT, reverse GCCGATCCACACGGAGTACT. For correlation analyses, Spearman and Pearson correlations were performed using the online tool GEPASv4.0, The Gene Expression Profile Analysis Suite (http://www.gepas.org) (Montaner et al., 2006) . Spearman and Pearson correlation coefficients, p values, as well as false discovery rates (FDR) were calculated using log2 ratios of experiment versus control for microarray data and DDC t values for real-time quantitative PCR.
RESULTS

Concentration Range and Time Point Findings
The concentrations selected for microarray analysis based on cytotoxicity tests are presented in Table 1 . Real-time PCR experiments resulted in a chosen time point of 20 h, based on limited gene expression changes at 3 and 6 h and overall maximal gene expression changes at 18 and 24 h (Fig. 1) . The effects of BaP exposure on CYP1B1 expression of the included samples without S9-mix showed to be low compared with the samples incubated in the presence of S9-mix. This suggests that BaP is transformed by metabolic enzymes in the S9-mix (e.g., CYP1A1) to different metabolites such as BPDE, which subsequently induce CYP1B1 (Hockley et al., 2007) , indicating the correct performance of the metabolic activation system.
Designation of Immunotoxic Test Conditions
We designated the different conditions, i.e., compounds and concentrations, as immunotoxic, nonimmunotoxic, or cytotoxic as presented in Table 1 . Of the 28 conditions, 10 conditions were considered to be cytotoxic, i.e., 4-HNE, 320.5lM; AA, 5mM; and 50mM; AFB1, 12.5 and 125mM; DON, 125 and 1250lM; IQ, 250lM; and PhIP, 25 and 250lM (Table 1) . These conditions were excluded from further analysis.
Gene Expression Analysis
The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession number GSE19078 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? acc¼GSE19078). Upon exposure to the test compounds, differentially expressed genes per condition were identified applying three different transcript selection criteria. Numbers of genes differentially expressed per condition are presented in Table 2 , which showed DON and PhIP to be outstanding. No common differentially expressed genes were found for all immunotoxic or for all nonimmunotoxic conditions. In order to visualize a possible separation between immunotoxic and nonimmunotoxic conditions, a PCA plot was generated; however, a clear separation was not found using either all transcripts (Fig. 2) or the filtered data (data not shown). DON and PhIP again showed to be outstanding.
To generate a gene expression profile indicative of exposure to immunotoxic compounds, SVM-RFE analysis was used. Three lists were generated, corresponding to the three different selection criteria used, each containing ranked transcripts based on significance for distinction of the immunotoxic from the nonimmuntoxic compounds. When selecting the top 100 ranked transcripts from each test, 48 transcripts were highly ranked in all ranking tests (intersection of the Venn diagram in Fig. 3) , providing a relevant gene subset potent in 22 distinguishing immunotoxic from the nonimmunotoxic conditions (Table 3) . Moreover, the gene set appeared to contain multiple immunologically relevant genes. Differences in direction of regulation between the two classes are however rather small (Fig. 4) . Taking the union or the intersection of the filtered data sets, performing a ranking as done for the single filtered data sets and then selecting as before the top 100, resulted in high overlaps (44 of the 48 genes as previously reported are in both top 100 ranking lists). This means we detect within these top 100 the same transcripts (data not shown).
As presented in Table 4 , for all of the tested genes, a significant correlation was found between microarray data and real-time quantitative PCR data, except for FEZ1 when using the Spearman correlation. Correlation coefficients ranging from 0.63 to 0.86 and p values all lower than 5.58 3 10 À11 (except for FEZ1) indicate a strong correlation between the two methods. Concordantly, combining all the genes resulted in highly significant p values and correlation coefficients not lower than 0.73.
GO Process Analysis
GO-Elite was able to associate 30 of the 48 reporters with one or more GO terms. Presented in Table 5 are the biological processes in which these genes are involved. The genes were shown to be involved in mainly immunerelated processes, such as cytokine production, negative regulation of cell proliferation, myeloid leukocyte activation, biological adhesion, and cellular locomotion.
DISCUSSION
In this study, the aim was to identify transcriptomic changes indicative of exposure to immunotoxic compounds. Using SVM-RFE, a set of 48 genes was identified, which is potent in distinguishing immunotoxic from the nonimmunotoxic conditions. Moreover, the set was found to be immunologically relevant on single gene level as well as on cellular process level. The observed transcriptional changes were verified with real-time quantitative PCR, establishing a good correlation between microarray and real-time quantitative PCR. Real-time quantitative PCR is generally considered as the most appropriate method to evaluate microarray-generated data, revealing significant correlation between the two different methods (Canales et al., 2006; Provenzano and Mocellin, 2007) . We acknowledge the fact that our concentrations are higher than occurring in humans at daily life exposure levels. As this study uses an in vitro system, relatively high concentrations were used in order to induce a quantifiable transcriptomic effect but were careful to avoid cytotoxic incubation concentrations. Subsequent in vivo studies are needed to evaluate whether the identified genes in this in vitro system are actually modulated in the human population.
When looking at the number of genes regulated by the individual test compounds, PhIP and DON showed to induce the highest number of genes. These compounds are clearly outstanding in the PCA plots. PCA, which is an unsupervised method, also showed no clear separation between the immunotoxic and the nonimmunotoxic conditions, suggesting that the difference in effects on gene expression between the two classes is rather low. The variance of the expression values does not allow seeing such a separation. Supervised algorithms like support vector machine, on the other hand, search specifically for genes which allow discrimination, based on the gene expression values. In order to generate one robust gene set indicative of exposure to immunotoxic compounds, results of the three different SVM-RFE analyses were FIG. 3 . Venn diagram of the top 100 transcripts of the three different SVM-RFE exercises, showing 48 genes to be present in all three tests. The union of all differentially expressed transcripts over all included conditions was used as input for the ranking tests, generating three gene lists, corresponding with the three different selection criteria used, i.e., (I) fold change ! 1.5 or 0.67 (average signals calculated on log values) and a coefficient of variance 0.5, (II) fold change ! 1.5 or 0.67 in three of five donors, or (III) a p value < 0.001 in a t-test of experiment versus control, analyzing the values from the two channels as separate experiments. (Fig. 3) , resulting in a list of 48 intersecting transcripts. Using these 48 genes, results in a 48-dimensional space, whereas in PCA, a 3-dimensional space is visualized by the components 1, 2, and 3, unable to show a clear separation between the two classes. Of these genes, 36 are annotated. This resulting gene set contains highly relevant genes for immunotoxicity based on their biological functions, as many genes are related to the immune (Loetscher et al., 1998) . Besides their obvious role in the immune response, CCR5 and CXCR7 have also been described to be involved in the development of different types of cancer (Vandercappellen et al., 2008) . This may be in line with the notion that immunotoxicity is known to play a role in carcinogenesis, while many carcinogenic compounds possess immunotoxic properties (Spinardi-Barbisan et al., 2004) . In fact, according to the International Agency for Research on Cancer (IARC), all the compounds used in this study, except for DON, are carcinogenic (http://www.iarc.fr/). Accordantly, angiogenin (ANG), a member of the RNase superfamily and a potent in vivo inducer of angiogenesis, was first isolated when investigating angiogenic factors secreted by human HT-29 colon adenocarcinoma cells (Fett et al., 1985) . As reviewed by Tello-Montoliu et al. (2006) , increased levels have been documented in different tumors, which are linked to disease progression and aggressiveness. Although it is known for its role in carcinogenesis, its normal physiologic function still remains to be fully elucidated. Possible roles of angiogenesis in the innate immune system have been proposed based on in vitro antimicrobial effects and protective effects against infection (Bedoya et al., 2006; Hooper et al., 2003) . IFI6 was also found to be affected upon immunotoxic exposure and is stimulated by interferon and thus is another gene related to cytokines (Porter et al., 1988) . In addition, other genes in our set code for proteins involved in related processes such as cell-to-cell and cell-to-matrix interactions. Thrombospondin 1 (THBS1) is an adhesive glycoprotein that can bind to different matrix proteins, i.e., type V collagen and fibronectin, and has a variety of functions. It is known to have stimulatory and inhibitory effects on T-cell function (Li et al., 2002) . Concordantly, in the present study, fibronectin 1 (FN 1) was also found to have a high potency in distinguishing immunotoxic from nonimmunotoxic conditions. In fact, FN 1 was even found to be the number one ranked gene.
Essential in the adaptive immune response is the activation of T and B cells. LAT2 (linker for activation of T cells family, member 2) in our gene set is a described T-cell and mast cell activator (Rivera, 2005) . Phosphoprotein 1 (SPP1), secreted by activated T lymphocytes, stimulates proliferation of B lymphocytes and production of immunoglobulins (Weber and Cantor, 1996) . Immunoglobin genes were also present in the generated gene set, such as immunoglobin J polypeptide (IGJ) and immunoglobin superfamily (IGSF6).
Besides looking at single genes, group-wise effects on GO terms were also investigated. Our gene set comprises a considerable number of immune-related genes, which is reflected in GO process analysis. Using the 48 genes for the enrichment analysis reveals specific immune-related categories enriched, like cytokine production, myeloid leukocyte activation, biological adhesion, cellular locomotion, and negative regulation of cell proliferation. Accordantly, cell cycle-related processes like the latter were also found to be affected in vivo by four different immunotoxic compounds in mice (Baken et al., 2008) .
No genes were found to be expressed by all immunotoxic conditions or by all nonimmunotoxic conditions. However, this does not rule out the possibility that there are common mechanisms through which the different compounds act in inducing immunotoxicity. Mechanisms or processes always involve multiple genes, so there remains the possibility that there are similar processes elicited by the different compounds, without modulating exactly the same transcripts.
As shown in Figure 4 , the difference in expression between the immunotoxic and the nonimmunotoxic conditions for most of the identified 48 genes is small. The ITX boxplots do have more outliers in the up (mostly) or down direction, indicating that the discrimination of the classes is partially based on these outliers. Because these represent individual chemical/concentration data points, this seems to suggest that this method will be very reliant on specific chemical testing concentrations, also indicating that the gene expression changes are dose dependent. These observations clearly indicate the need for more extensive concentration-response studies to define the dynamic range of the window available for detecting marker gene modulation.
In conclusion, we believe that using SVM-RFE, a promising gene set is generated indicative of immunotoxic in vitro exposure in human PBMC since it contains 48 genes which are potent in distinguishing immunotoxic from nonimmunotoxic conditions. Moreover, of the 36 annotated genes, a considerable number of genes appear to be highly immunologically relevant, involved in multiple immune-related processes. These genes might be considered as candidate biomarker genes for immunotoxicity screening based on transcriptomics. However, whether the observed genes show similar responses in the human population has to be investigated in subsequent in vivo studies. 
